Atlas Trials

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Clinical trial NCT02649608 · COMPLETED

Trial details

NCT number
NCT02649608
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2016-01-01
Primary completion
2016-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.